Home
News
Media
All VideosClinical Trials in ProgressImmunoLogicNews Network
Partners
More
CME/CE
Conferences
Sponsored

Subscribe

  • Home
  • News
  • Media
  • Partners
  • CME/CE
  • Conferences
  • Sponsored
  • Subscribe
  • Cardiology
  • Dermatology
  • Endocrinology
  • Hematology
  • Lysosomal Disorders
  • Neurology
  • Oncology
  • Ophthalmology
Advertisement

Mufti N. Ahmad, MD, FACP

Advertisement

Articles by Mufti N. Ahmad, MD, FACP

Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors

ByKathryn F. Mileham, MD, FACP,Mufti N. Ahmad, MD, FACP,Edward S. Kim, MD, FACP
April 15th 2019

In this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.

Advertisement

Latest Updated Articles

  • Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors
    Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors

    Published: April 15th 2019 | Updated:



Advertisement
Advertisement

Trending on CGTlive®

1

Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025

2

Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE

3

Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?

4

Guess the Therapy Answer October 29, 2025

5

Quarter Century Update: What Does the Field Need Most Right Now?

  • About Us
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Do Not Sell My Information
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • HCP Live
  • Contagion Live
  • CGT Live
  • Neurology Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us